Condition: Breast Cancer Female · Sponsor: International Agency for Research on Cancer
Breast cancer has become a major public health problem in Latin America, as it is the most common form of cancer among women. Women are more likely to develop breast cancer at younger age, and to be diagnosed at an advanced stage compared to western women. Over the past twenty years, the mortality from breast cancer in Latin America has also been increasing very rapidly, and is currently the leading cause of cancer mortality. Little is known on specific risk factors for premenopausal breast cancer in general, and in Latin America in particular. There is a lack of specific knowledge on tumor molecular and pathological characteristics of breast cancer in Latin America premenopausal women, and this has major consequences on cancer treatment and survival. To improve our understanding on determinants of breast cancer incidence and mortality in young Latin America women and support preventive actions, we implemented an international, population-based multi-center study in Latin America: the PRECAMA study (Molecular Subtypes of Premenopausal Breast Cancer in Latin American Women (PRECAMA): a multicenter population-based case-control study). PRECAMA is coordinated by the International Agency for Research on Cancer (IARC), and is conducted within 4 Latin American countries: Mexico, Costa Rica, Colombia and Chile. Major aims of the project are the following: 1. To develop a multi-centric population-based case-control study on breast cancer in premenopausal women in several countries…
This description comes directly from the study's public registry record.
Sabina Rinaldi, PhD · +33 472738485 · rinaldis@iarc.who.int
Always discuss trial participation with your own doctor first.
| Barretos Cancer Hospital | Barretos, Brazil | Completed |
| INC | Santiago, Independencia, Chile | Active Not Recruiting |
| Hso-Crsco | Santiago, Peñalolén, Chile | Active Not Recruiting |
| FALP | Santiago, Providencia, Chile | Active Not Recruiting |
| Grupo Infección y Cáncer. Universidad de Antioquia | Medellín, Antioquia, Colombia | Recruiting |
| International Hospital of Colombia | Bucaramanga, Bucaramanga, Colombia | Recruiting |
| Facultad de Medicina, Universidad del Norte | Barranquilla, Colombia | Completed |
| Hospital Internacional de Colombia Fundacion Cardiovascular de Colombia | Bucaramanga, Colombia | Recruiting |
| SENOSAMA foundation | Bucaramanga, Colombia | Recruiting |
| Instituto de Oncología HematoOncologos | Cali, Colombia | Completed |
| Public Health University of Narino | Pasto, Colombia | Recruiting |
| Agencia Costarricense de Investigaciones Biomédicas (ACIB) | San José, Provincia de San José, Costa Rica | Completed |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03144648